Overview

Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This open-label study is being conducted to evaluate the long-term safety, tolerability, and efficacy of avanafil in men with mild to severe erectile dysfunction. Approximately 400 subjects will be enrolled and treated with avanafil for up to 52 weeks.
Phase:
Phase 3
Details
Lead Sponsor:
VIVUS, Inc.